Magazine article from our research archive:
|
|
Drug trial data is just the tonic for Glaxo.
- Article from:
-
Investors Chronicle
- Article date:
-
December 1, 2006
|
Copyright informationCOPYRIGHT 2006 FT Business. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
News that Novartis' new diabetes product, Galvus, has disappointed in the clinic is a shot in the arm for GlaxoSmithKline (GSK). The drug is a potential rival to GSK's Avandia. But two-year trial data released this week shows that Galvus is not as effective as metformin, the industry-standard drug, in cutting ...
Related newspaper, magazine, and journal articles:
|
GlaxoSmithKline Clarifies Availability of Clinical Trial Data on...
PR Newswire;
June 10, 2004 ;
376 words
......results. With regard to clinical trial data on paroxetine, GSK has already provided data that...clarify the nature of these data, GSK will shortly be making available...company's corporate website (http://www.gsk.com/). Paroxetine has not been...
|
|
Trial data boost for Intercytex.
Investors Chronicle - magazine and web content;
September 26, 2007 ;
243 words
......delivered consistently better-than-expected trial data and the group looks well funded following...of cosmetic treatments. And important trial data is expected on the wound therapies next...pivotal time for Intercytex. And, if the trial data is positive, as seems feasible, then...
|
|
Internet study finds clinical trial data lagging.(Practice Trends)
Skin & Allergy News;
July 1, 2005 ;
577 words
......concealment of clinical trial data, two pharmaceutical...release of clinical trial data on the use of paroxetine...trial results for all GSK drugs on its corporate...supplies clinical trial data on all its psychotropic...such complete clinical trial data ...
|
|
Cook Group cuts against the grain in advocating public access to trial...
Medical Design Technology;
December 1, 2004 ;
669 words
......allowing FDA to share manufacturer clinical trial data publicly, reports The Gray Sheet. FDA...confidential and proprietary clinical trial data would eliminate the need for much bench...favor of more disclosure of proprietary trial data. I can't wait to hear what AdvaMed has...
|
|
Data restriction could cost lives.(Generics)(clinical trial data)(Brief...
Chemistry and Industry;
February 26, 2007 ;
115 words
...The exclusive fights of pharmaceutical companies to clinical trial data could endanger lives in the event of a global flu pandemic...a personal capacity, says that without access to clinical trial data, generics manufacturers would need to carry out their own...
|
|
Publication of clinical trial data.(International Report)(Medicines and...
Information Today;
January 1, 2005 ;
700+ words
......that GlaxoSmithKline's (GSK) antidepressant drug...only publish selective trial data (i.e., exclude negative...their market position. GSK has now made available...Pressure to publish clinical trial data in the U.K. mirrors...companies to publish trial data with the ...
|
|
Amgen and Campbell Alliance to Speak at CBI's Optimize Clinical Trial Data...
PR Newswire;
September 14, 2005 ;
493 words
......Alliance will speak at the Optimize Clinical Trial Data Collection and Exchange conference to...consulting firm. At CBI's Optimize Clinical Trial Data Collection and Exchange conference industry...timelines and metrics, integrating clinical trial data with standardized CRFs, ...
|
|
Cambridge Antibody shares hit by trial data.
Investors Chronicle;
October 14, 2005 ;
94 words
......Cambridge Antibody Technology (CAT) fell 4 per cent after US licensing partner Human Genome Sciences (HGS) unveiled mixed trial data. Phase II trials of CAT's lupus drug, LymphoStat-B, did not achieve their clinical endpoints. But a majority patient subgroup...
|
|
The Immune Response Corporation Announces Arbitration Proceedings And...
PR Newswire;
October 31, 2000 ;
700+ words
......comments in the publication of clinical trial data of REMUNE(TM) (HIV-1 Immunogen) from...to ensure that confidential clinical trial data from Study 806 of REMUNE would not be...supporter of publication of clinical trial data, said Ronald B. Moss, M.D., Vice President...
|
|
French biotechnology company.(Neurotechnology's pre-clinical trial...
Chemistry and Industry;
December 18, 2000 ;
79 words
......cell technology to deliver therapeutic proteins to the eye and CNS (C&I 2000, 592), has reported positive pre-clinical trial data. Neurotech announced its product gave significant protection against retinal degeneration in an animal model of retinitus...
|
|
Carmel, Ind.-Based Clinical Trial Data Systems Firm Files for Bankruptcy.
Knight Ridder/Tribune Business News;
May 26, 1999 ;
197 words
......filed for Chapter 11 bankruptcy protection. Founded in 1994, Avantec Inc. manages the collection and organization of clinical trial data, helping clients get experimental treatments to market faster. The company developed a proprietary software system that allows...
|
|
FDA announces standard format that drug sponsors can use to submit human...
M2 Presswire;
July 21, 2004 ;
555 words
......can use to submit human drug clinical trial data(C)1994-2004 M2 COMMUNICATIONS LTD RDATE...standard for the exchange of clinical trial data cannot be overstated, said Dr. Lester...barriers for sharing the latest clinical trial data. FDA's Critical Path initiative is focused...
|
|
Trial data boosts Vernalis.
Investors Chronicle - magazine and web content;
June 13, 2007 ;
99 words
......migraine drug, Frova. Piper Terrett Shares in Vernalis perked after the company's US partner Endo presented positive Phase III trial data at a prestigious US conference. Results from the studies showed that Frova, Vernalis's drug for menstrually associated migraine...
|
|
The American College of Cardiology's Board of Trustees approved sanctions...
Medical Marketing & Media;
July 1, 2007 ;
57 words
......College of Cardiology's Board of Trustees approved sanctions against a physician for leaks that broke an embargo on COURAGE trial data presented at the ACC's March Annual Scientific Session. Dr. Martin Leon, of Columbia University, will be prohibited from participating...
|
See all results.
Or, try our
Advanced Search.
|